KEGG   DRUG: Efgartigimod alfa and hyaluronidase
Entry
D12684            Mixture   Drug                                   
Name
Efgartigimod alfa and hyaluronidase;
Efgartigimod alfa (genetical recombination) and vorhyaluronidase alfa (genetical recombination);
Efgartigimod alfa and hyaluronidase-qvfc;
Vyvgard hytrulo (TN);
Vyvdura (TN)
Product
VYVGART HYTRULO (argenx US)
Component
Efgartigimod alfa [DR:D11876], Hyaluronidase (human recombinant) [DR:D06604]
Remark
Therapeutic category: 6399
ATC code: L04AA58
Product: D12684<JP/US>
Efficacy
Autoimmune disease treatment
  Disease
Generalized myasthenia gravis (AChR antibody positive) [DS:H01594]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AA Selective immunosuppressants
     L04AA58 Efgartigimod alfa
      D12684  Efgartigimod alfa and hyaluronidase <JP/US>
USP drug classification [BR:br08302]
 Antimyasthenic Agents
  Efgartigimod Alfa/ Hyaluronidase
   D12684  Efgartigimod alfa and hyaluronidase
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   639  Miscellaneous
    6399  Others
     D12684  Efgartigimod alfa and hyaluronidase
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D12684
Other DBs
PubChem: 497621097
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system